Panagora Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-82,849
Closed -$1.7M 1257
2024
Q2
$1.7M Sell
82,849
-154,157
-65% -$3.16M 0.01% 563
2024
Q1
$5.64M Buy
237,006
+62,862
+36% +$1.5M 0.03% 319
2023
Q4
$3.76M Buy
174,144
+82,645
+90% +$1.79M 0.02% 386
2023
Q3
$1.33M Sell
91,499
-175,583
-66% -$2.55M 0.01% 684
2023
Q2
$5.59M Buy
267,082
+84,701
+46% +$1.77M 0.03% 308
2023
Q1
$3.85M Buy
182,381
+3,296
+2% +$69.6K 0.02% 423
2022
Q4
$4.56M Buy
179,085
+110,282
+160% +$2.81M 0.03% 407
2022
Q3
$1.65M Sell
68,803
-138,015
-67% -$3.32M 0.01% 670
2022
Q2
$3.98M Sell
206,818
-3,017
-1% -$58K 0.03% 441
2022
Q1
$3.65M Buy
209,835
+8,993
+4% +$156K 0.02% 495
2021
Q4
$4.4M Sell
200,842
-3,339
-2% -$73.1K 0.02% 435
2021
Q3
$3.9M Sell
204,181
-1,820
-0.9% -$34.8K 0.02% 489
2021
Q2
$3.54M Buy
206,001
+83,361
+68% +$1.43M 0.02% 528
2021
Q1
$2.74M Buy
122,640
+12,331
+11% +$276K 0.02% 630
2020
Q4
$2.45M Buy
110,309
+55,020
+100% +$1.22M 0.01% 628
2020
Q3
$816K Sell
55,289
-14,186
-20% -$209K 0.01% 972
2020
Q2
$1.03M Hold
69,475
0.01% 922
2020
Q1
$761K Sell
69,475
-62,004
-47% -$679K 0.01% 947
2019
Q4
$1.15M Sell
131,479
-78,677
-37% -$691K 0.01% 1002
2019
Q3
$1.57M Buy
210,156
+11,986
+6% +$89.5K 0.01% 843
2019
Q2
$1.85M Buy
198,170
+50,030
+34% +$466K 0.01% 870
2019
Q1
$778K Sell
148,140
-12,155
-8% -$63.8K ﹤0.01% 1230
2018
Q4
$713K Buy
160,295
+3,782
+2% +$16.8K ﹤0.01% 1210
2018
Q3
$1.27M Buy
156,513
+69,130
+79% +$559K ﹤0.01% 1029
2018
Q2
$613K Buy
87,383
+31,125
+55% +$218K ﹤0.01% 1337
2018
Q1
$801K Sell
56,258
-24,798
-31% -$353K ﹤0.01% 1238
2017
Q4
$710K Buy
+81,056
New +$710K ﹤0.01% 1259